会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • PROCESSES FOR THE PREPARATION OF CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S
    • 制备CATHEPSIN的碳链烷基四氢吡喃 - 吡啶调节剂的方法
    • WO2009102937A1
    • 2009-08-20
    • PCT/US2009/034031
    • 2009-02-13
    • SUNESIS PHARMACEUTICALS, INC.MANI, Neelakandha, S.LIANG, Jimmy, T.DENG, Xiaohu
    • MANI, Neelakandha, S.LIANG, Jimmy, T.DENG, Xiaohu
    • C07D471/04
    • C07D471/04
    • Method of making carbon-linked tetrahydro-pyrazolo-pyridine compounds of the following Formula (I) and pharmaceutically acceptable salts thereof: comprising reacting a compound of formula (IX): with a compound of formula (X): to form a compound of Formula (I); wherein: R 1 and R 7 taken together with the nitrogen to which they are attached form a morpholine ring, unsubstituted or substituted with one or two methyl substituents; R 3 is H or OH; R 4 is -SO 2 CH 3 , -CONH 2 , or -COCONH 2 ; R 5 is H or methyl; R 6 is a benzyl group, unsubstituted or substituted with one or two substituents independently selected from the group consisting of C 1-4 alkyl, CF 3 , halo, OH, -OC 1-4 alkyl, -OCF 3 , -OCHF 2 , NR dd R ee , -CO 2 C 1-4 alkyl, -SC 1-4 alkyl, and -SO 2 C 1-4 alkyl; where R dd and R ee are each independently H or C 1-4 alkyl; R 7 is H, fluoro, or chloro; and LG 1 is iodide, bromide, or trifluoromethanesulfonate. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by cathepsin S activity, such as psoriasis, pain, multiple sclerosis, atherosclerosis, and rheumatoid arthritis.
    • 制备下式(I)的碳 - 连四氢 - 吡唑并 - 吡啶化合物及其药学上可接受的盐的方法:包括使式(Ⅸ)化合物与式(Ⅹ)化合物反应:使式 (一世); 其中:R 1和R 7与它们所连接的氮一起形成吗啉环,未被取代或被一个或两个甲基取代基取代; R3是H或OH; R4是-SO2CH3,-CONH2或-COCONH2; R5是H或甲基; R6是未取代的或被一个或两个取代基取代的苄基,所述取代基独立地选自C 1-4烷基,CF 3,卤素,OH,-OC 1-4烷基,-OCF 3,-OCHF 2,NR d R e,-CO 2 C 1-4烷基, SC1-4烷基和-SO2C1-4烷基; 其中Rdd和Ree各自独立地为H或C 1-4烷基; R7是H,氟或氯; 和LG1是碘化物,溴化物或三氟甲磺酸盐。 这些化合物可用于治疗由组织蛋白酶S活性介导的疾病状态,病症和病症的药物组合物和方法,例如银屑病,疼痛,多发性硬化,动脉粥样硬化和类风湿性关节炎。